comprehensive -WSS

comprehensive

author：comprehensive 2025-08-26 23:48:03 - browse：5

A colorful illustrated montage of money, people in suits, and pills – business, politics and policy coverage from STAT — Mike Reddy for STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

We did something a little different for this issue: We wanted to share some of the stories that explain the machinations of the U.S. health care system — stories that really influenced how we think about and report on this industry. Drop us a line to let us know which stories have resonated with you over the years: [email protected] and [email protected].

‘It’s The Prices, Stupid’

Everyone’s first major encounter with the health care system usually results in surprise and confusion. Whether it’s childbirth, caring for a family member, or dealing with one’s own injury or illness, a bill inevitably comes in the mail leaving most people asking, “Why does everything cost so much?” The answer invariably comes back to a popular 2003 journal article from a quartet of health economists titled, “It’s The Prices, Stupid.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Doctors' information doesn't help them choose wisely when sick

explore

WSS

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

KalVista pill reduced swelling 'attacks' caused by genetic disease

Vaccine advisory panel ACIP left half staffed by HHS

What we’ve learned from the Aduhelm mess

Medicare Advantage proposed rates disappoint insurers

Democrats decry new health bill for going easy on private equity

hotspot

comprehensive

‘It’s The Prices, Stupid’

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

How one medical school became remarkably diverse

Key House Republican on health care plans exit from Congress

Medical records are filled with copy

Truvian presents data for its desktop blood

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Search called off for baby washed away in Pennsylvania flash flood

The cancer drug shortage isn’t new — and neither are the solutions

A disappointing year of Humira biosimilars

entertainment

Biogen Alzheimer’s drug launch off to slow start

Dems pitch expanding Medicare power to negotiate drug prices

What to watch for from Zogenix and Amicus clinical trials

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

PhRMA lawsuit over Medicare drug price negotiation tossed

New lawsuit accuses health insurer Cigna of denying claims in bulk

focus

explore

explore

explore